Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,284 | 84,132 | 91,994 | 105,257 | 55,696 |
| Marketable Securities | 11,508 | 34,101 | 44,991 | 49,665 | N/A |
| Receivables | 834 | 151 | 136 | N/A | N/A |
| Inventories | 7,830 | 918 | N/A | N/A | N/A |
| Other current assets | 4,140 | 2,743 | 1,155 | 1,440 | 1,232 |
| TOTAL | $98,596 | $122,045 | $138,276 | $156,362 | $56,928 |
| Non-Current Assets | |||||
| PPE Net | 1,532 | 1,363 | 1,048 | 538 | 349 |
| Intangibles | 3,208 | 3,208 | 3,208 | 3,208 | 3,208 |
| Other Non-Current Assets | 292 | 292 | 362 | 217 | 281 |
| TOTAL | $5,032 | $4,863 | $4,618 | $3,963 | $3,838 |
| Total Assets | $103,628 | $126,908 | $142,894 | $160,325 | $60,766 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,146 | 25,138 | 17,226 | 15,955 | 14,004 |
| Accrued Expenses | 4,751 | 2,987 | 1,285 | 414 | 1,324 |
| TOTAL | $29,311 | $28,125 | $18,511 | $16,369 | $15,328 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 414 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 133 | 75 | 78 | 41 | 38 |
| TOTAL | $833 | $75 | $78 | $41 | $38 |
| Total Liabilities | $30,144 | $28,200 | $18,589 | $16,410 | $15,366 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,596 | 91,940 | 91,820 | 91,453 | 90,912 |
| Common Shares | 93 | 92 | 92 | 91 | 83 |
| Retained earnings | -550,858 | -510,573 | -475,284 | -452,870 | -439,340 |
| Other shareholders' equity | -357 | -357 | -357 | -357 | -357 |
| TOTAL | $73,484 | $98,708 | $124,305 | $143,915 | $45,400 |
| Total Liabilities And Equity | $103,628 | $126,908 | $142,894 | $160,325 | $60,766 |